Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionintegrin binding involved in cell-matrix adhesion

ITGA9 SVEP1

3.15e-055362GO:0098640
GeneOntologyMolecularFunctioncell-matrix adhesion mediator activity

ITGA9 SVEP1

1.13e-049362GO:0098634
GeneOntologyMolecularFunctionzinc ion binding

BMP1 ZNF208 ZNF214 CPSF4 PPARA ZNF90 ZNF92

9.23e-04891367GO:0008270
GeneOntologyMolecularFunctionRNA polymerase II cis-regulatory region sequence-specific DNA binding

ZNF208 CPHXL PPARA ZNF90 EZH2 ZNF107 ZNF607 ZNF92

1.40e-031244368GO:0000978
GeneOntologyMolecularFunctioncis-regulatory region sequence-specific DNA binding

ZNF208 CPHXL PPARA ZNF90 EZH2 ZNF107 ZNF607 ZNF92

1.61e-031271368GO:0000987
GeneOntologyBiologicalProcesspositive regulation of viral process

SRPK1 SRPK2 PPARA CNOT7

5.55e-0669354GO:0048524
GeneOntologyBiologicalProcesspositive regulation of viral genome replication

SRPK1 SRPK2 CNOT7

1.95e-0531353GO:0045070
HumanPhenoWide distal femoral metaphysis

BMP1 EZH2

6.93e-06462HP:0006387
HumanPhenoAbnormal distal femoral metaphysis morphology

BMP1 EZH2

1.15e-05562HP:0030299
HumanPhenoWide femoral metaphysis

BMP1 EZH2

1.73e-05662HP:0006417
HumanPhenoAbnormality of the humerus

BMP1 IFT122 EZH2

4.42e-056863HP:0003063
HumanPhenoAbnormality of the upper arm

BMP1 IFT122 EZH2

7.49e-058163HP:0001454
HumanPhenoThin nail

IFT122 EZH2

1.38e-041662HP:0001816
HumanPhenoAbnormality of the tubular bones

LRP4 BMP1 IFT122 EZH2 EFEMP2

1.56e-0463265HP:0100713
HumanPhenoAbnormality of the long tubular bones

LRP4 BMP1 IFT122 EZH2 EFEMP2

1.56e-0463265HP:0100714
HumanPhenoAbnormal femoral metaphysis morphology

BMP1 EZH2

2.40e-042162HP:0006489
HumanPhenoAbnormal diaphysis morphology

LRP4 BMP1 IFT122 EFEMP2

2.72e-0434364HP:0000940
HumanPhenoAbnormal lower-limb metaphysis morphology

BMP1 EZH2

2.89e-042362HP:0006490
HumanPhenoAbnormality involving the metaphyses of the limbs

BMP1 EZH2

4.31e-042862HP:0006506
HumanPhenoAbnormal long bone morphology

LRP4 BMP1 IFT122 EZH2 EFEMP2

5.60e-0482165HP:0011314
HumanPhenoAbnormal toenail morphology

LRP4 IFT122 EZH2

6.44e-0416763HP:0008388
HumanPhenoLimitation of knee mobility

BMP1 EZH2

6.76e-043562HP:0010501
HumanPhenoAbnormal morphology of bones of the upper limbs

LRP4 BMP1 IFT122 EZH2

6.91e-0443664HP:0040065
HumanPhenoAbnormal rib cage morphology

LRP4 BMP1 IFT122 EZH2

7.48e-0444564HP:0001547
HumanPhenoAbnormal toe morphology

LRP4 BMP1 IFT122 EZH2 EFEMP2

8.41e-0489365HP:0001780
HumanPhenoAbnormal sternum morphology

LRP4 BMP1 IFT122 EFEMP2

9.54e-0447464HP:0000766
HumanPhenoAbnormal upper limb bone morphology

LRP4 BMP1 IFT122 EZH2

1.03e-0348464HP:0040070
HumanPhenoHernia of the abdominal wall

BMP1 IFT122 EZH2 EFEMP2

1.23e-0350664HP:0004299
HumanPhenoAbdominal wall defect

BMP1 IFT122 EZH2 EFEMP2

1.27e-0351164HP:0010866
HumanPhenoThoracoabdominal wall defect

BMP1 IFT122 EZH2 EFEMP2

1.27e-0351164HP:0100656
HumanPhenoAbnormal nail morphology

LRP4 MYOF IFT122 EZH2

1.32e-0351664HP:0001597
HumanPhenoFinger syndactyly

LRP4 IFT122 EZH2

1.40e-0321863HP:0006101
HumanPhenoProtruding ear

LRP4 BMP1 IFT122

1.42e-0321963HP:0000411
HumanPhenoTall stature

LRP4 EZH2 EFEMP2

1.54e-0322563HP:0000098
HumanPhenoAbnormal fingernail morphology

LRP4 IFT122 EZH2

1.64e-0323063HP:0001231
HumanPhenoJoint hypermobility

BMP1 IFT122 EZH2 EFEMP2

1.77e-0355764HP:0001382
HumanPhenoAbnormality of the abdominal wall

BMP1 IFT122 EZH2 EFEMP2

1.81e-0356064HP:0004298
HumanPhenoAbnormal odontoid tissue morphology

LRP4 BMP1 IFT122

1.81e-0323863HP:3000050
HumanPhenoHernia

BMP1 IFT122 EZH2 EFEMP2

2.19e-0358964HP:0100790
HumanPhenoAplasia/Hypoplasia of the nails

LRP4 IFT122 EZH2

2.29e-0325863HP:0008386
HumanPhenoNail dysplasia

LRP4 IFT122 EZH2

2.45e-0326463HP:0002164
DomainEGF_CA

LRP4 BMP1 SVEP1 EFEMP2

1.97e-0586354PF07645
DomainEGF_Ca-bd_CS

LRP4 BMP1 SVEP1 EFEMP2

3.16e-0597354IPR018097
DomainEGF_CA

LRP4 BMP1 SVEP1 EFEMP2

3.43e-0599354PS01187
DomainASX_HYDROXYL

LRP4 BMP1 SVEP1 EFEMP2

3.57e-05100354PS00010
DomainEGF-type_Asp/Asn_hydroxyl_site

LRP4 BMP1 SVEP1 EFEMP2

4.48e-05106354IPR000152
DomainEGF_CA

LRP4 BMP1 SVEP1 EFEMP2

7.76e-05122354SM00179
DomainEGF-like_Ca-bd_dom

LRP4 BMP1 SVEP1 EFEMP2

8.26e-05124354IPR001881
DomainGrowth_fac_rcpt_

LRP4 BMP1 SVEP1 EFEMP2

2.00e-04156354IPR009030
Domainzf-C2H2_6

ZNF208 ZNF90 ZNF107 ZNF607 ZNF92

2.79e-04314355PF13912
DomainKRAB

ZNF208 ZNF214 ZNF90 ZNF607 ZNF92

5.09e-04358355PS50805
DomainKRAB

ZNF208 ZNF214 ZNF90 ZNF607 ZNF92

5.09e-04358355PF01352
DomainKRAB

ZNF208 ZNF214 ZNF90 ZNF607 ZNF92

5.84e-04369355SM00349
DomainKRAB

ZNF208 ZNF214 ZNF90 ZNF607 ZNF92

5.91e-04370355IPR001909
DomainEGF_3

LRP4 BMP1 SVEP1 EFEMP2

9.42e-04235354PS50026
DomainEGF

LRP4 BMP1 SVEP1 EFEMP2

9.42e-04235354SM00181
DomaincEGF

LRP4 EFEMP2

1.08e-0326352IPR026823
DomaincEGF

LRP4 EFEMP2

1.08e-0326352PF12662
DomainEGF-like_dom

LRP4 BMP1 SVEP1 EFEMP2

1.17e-03249354IPR000742
DomainEGF_1

LRP4 BMP1 SVEP1 EFEMP2

1.27e-03255354PS00022
DomainEGF-like_CS

LRP4 BMP1 SVEP1 EFEMP2

1.39e-03261354IPR013032
DomainEGF_2

LRP4 BMP1 SVEP1 EFEMP2

1.47e-03265354PS01186
Domain-

ZNF208 ZNF214 ZNF90 ZNF107 ZNF607 ZNF92

1.49e-036793563.30.160.60
Domainzf-C2H2

ZNF208 ZNF214 ZNF90 ZNF107 ZNF607 ZNF92

1.65e-03693356PF00096
DomainZnf_C2H2/integrase_DNA-bd

ZNF208 ZNF214 ZNF90 ZNF107 ZNF607 ZNF92

1.66e-03694356IPR013087
DomainEGF

LRP4 BMP1 SVEP1

1.68e-03126353PF00008
DomainZINC_FINGER_C2H2_2

ZNF208 ZNF214 ZNF90 ZNF107 ZNF607 ZNF92

2.90e-03775356PS50157
DomainZINC_FINGER_C2H2_1

ZNF208 ZNF214 ZNF90 ZNF107 ZNF607 ZNF92

2.94e-03777356PS00028
DomainZnf_C2H2-like

ZNF208 ZNF214 ZNF90 ZNF107 ZNF607 ZNF92

3.31e-03796356IPR015880
DomainZnf_C2H2

ZNF208 ZNF214 ZNF90 ZNF107 ZNF607 ZNF92

3.50e-03805356IPR007087
DomainZnF_C2H2

ZNF208 ZNF214 ZNF90 ZNF107 ZNF607 ZNF92

3.57e-03808356SM00355
Pubmed

Clustered organization of homologous KRAB zinc-finger genes with enhanced expression in human T lymphoid cells.

ZNF208 ZNF90 ZNF107 ZNF92

1.74e-09163648467795
Pubmed

Inactivating frameshift mutation of putative tumor suppressor genes PLA2R1 and SRPK1 in gastric and colorectal cancers.

SRPK1 PLA2R1

1.04e-06236228212809
Pubmed

The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro.

SRPK1 SRPK2

1.04e-06236232817937
Pubmed

Serine-arginine protein kinases: a small protein kinase family with a large cellular presence.

SRPK1 SRPK2

1.04e-06236221205200
Pubmed

Inhibition of hepatitis C virus replication by a specific inhibitor of serine-arginine-rich protein kinase.

SRPK1 SRPK2

1.04e-06236220498328
Pubmed

Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein.

SRPK1 SRPK2

1.04e-06236212134018
Pubmed

Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340).

SRPK1 SRPK2

1.04e-06236226244849
Pubmed

Novel SR-protein-specific kinase, SRPK2, disassembles nuclear speckles.

SRPK1 SRPK2

1.04e-0623629446799
Pubmed

Suppression of hepatitis B virus replication by SRPK1 and SRPK2 via a pathway independent of the phosphorylation of the viral core protein.

SRPK1 SRPK2

1.04e-06236216122776
Pubmed

Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.

ZNF208 ZNF90 ZNF107 ZNF607 ZNF92

1.19e-0618136537372979
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

PDS5A SRPK1 MYOF SRPK2 CPSF4 EZH2 ACTR5 PARP2 MINK1 CNOT7

1.93e-061497361031527615
Pubmed

Exome sequencing of two Italian pedigrees with non-isolated Chiari malformation type I reveals candidate genes for cranio-facial development.

LRP4 BMP1

3.12e-06336228513615
Pubmed

Human autoimmune sera as molecular probes for the identification of an autoantigen kinase signaling pathway.

SRPK1 SRPK2

3.12e-06336212417631
Pubmed

The subcellular localization of SF2/ASF is regulated by direct interaction with SR protein kinases (SRPKs).

SRPK1 SRPK2

3.12e-06336210196197
Pubmed

SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer's disease.

SRPK1 SRPK2

3.12e-06336223197718
Pubmed

SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma.

SRPK1 SRPK2

6.24e-06436233602301
Pubmed

SVEP1 is a human coronary artery disease locus that promotes atherosclerosis.

ITGA9 SVEP1

6.24e-06436233762433
Pubmed

Transcription Dynamics Prevent RNA-Mediated Genomic Instability through SRPK2-Dependent DDX23 Phosphorylation.

SRPK1 SRPK2

6.24e-06436228076779
Pubmed

The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9β1 and α4β1.

ITGA9 SVEP1

6.24e-06436235802072
Pubmed

Activity and subcellular compartmentalization of peroxisome proliferator-activated receptor alpha are altered by the centrosome-associated protein CAP350.

CEP350 PPARA

1.04e-05536215615782
Pubmed

Effect of cisplatin treatment on speckled distribution of a serine/arginine-rich nuclear protein CROP/Luc7A.

SRPK1 SRPK2

1.04e-05536212565863
Pubmed

Polydom/SVEP1 is a ligand for integrin α9β1.

ITGA9 SVEP1

1.04e-05536222654117
Pubmed

Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin.

SRPK1 SRPK2

1.04e-05536221157427
Pubmed

A serine kinase regulates intracellular localization of splicing factors in the cell cycle.

SRPK1 SRPK2

2.18e-0573628208298
Pubmed

An Evolutionarily Conserved Role for Polydom/Svep1 During Lymphatic Vessel Formation.

ITGA9 SVEP1

2.91e-05836228179432
Pubmed

The evolutionarily conserved Krüppel-associated box domain defines a subfamily of eukaryotic multifingered proteins.

ZNF90 ZNF92

2.91e-0583622023909
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

CEP350 LRP4 SRPK2 ZNF214 IFT122 ZNF92 EFEMP2 OSBPL1A

4.08e-05128536835914814
Pubmed

Localization of serine kinases, SRPK1 (SFRSK1) and SRPK2 (SFRSK2), specific for the SR family of splicing factors in mouse and human chromosomes.

SRPK1 SRPK2

4.66e-051036210198174
Pubmed

Functional analysis of the SRY-KRAB interaction in mouse sex determination.

ZNF208 ZNF107

4.66e-051036218588511
Pubmed

WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.

PDS5A EZH2 ACTR5 PARP2 PPM1G

5.14e-0539436527248496
Pubmed

Sry associates with the heterochromatin protein 1 complex by interacting with a KRAB domain protein.

ZNF208 ZNF107

5.70e-051136215469996
Pubmed

SRPK2: a differentially expressed SR protein-specific kinase involved in mediating the interaction and localization of pre-mRNA splicing factors in mammalian cells.

SRPK1 SRPK2

5.70e-05113629472028
Pubmed

Epigenetic gene silencing by the SRY protein is mediated by a KRAB-O protein that recruits the KAP1 co-repressor machinery.

ZNF208 ZNF107

8.07e-051336219850934
Pubmed

Expansion and diversification of KRAB zinc-finger genes within a cluster including Regulator of sex-limitation 1 and 2.

ZNF208 ZNF107

1.08e-041536215885501
Pubmed

Genome-wide analysis of sex-specific differences in the mother-child PELAGIE cohort exposed to organophosphate metabolites.

PPARA EZH2

1.40e-041736237198424
Pubmed

Characterization of the interaction of Aha1 with components of the Hsp90 chaperone machine and client proteins.

SRPK1 PPM1G

1.96e-042036222504172
Pubmed

Evidence for genes on chromosome 2 contributing to alcohol dependence with conduct disorder and suicide attempts.

VWC2L PPM1G

2.60e-042336220468071
Pubmed

Regulator of sex-limitation (Rsl) encodes a pair of KRAB zinc-finger genes that control sexually dimorphic liver gene expression.

ZNF208 ZNF107

4.16e-042936214563677
Pubmed

Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2.

SRPK1 SRPK2

4.75e-043136216140986
Pubmed

Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function.

MPP3 M6PR

5.07e-043236212493773
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

SRPK1 SRPK2 IFT122 EZH2 MINK1

5.24e-0465036538777146
Pubmed

Transcriptome analysis of mouse stem cells and early embryos.

MYOF CPSF4 ITGA9 CNOT7

5.28e-0436336414691545
Pubmed

Human transcription factor protein interaction networks.

PDS5A CPSF4 ZNF107 ZNF607 ACTR5 PPM1G CNOT7

5.71e-04142936735140242
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

LRP4 PDS5A SRPK1 MYOF PARP2 PPM1G CNOT7

5.97e-04144036730833792
Pubmed

Charting the landscape of tandem BRCT domain-mediated protein interactions.

CEP350 SRPK1 SRPK2 CPSF4 PPM1G

6.01e-0467036522990118
Pubmed

The protein interaction landscape of the human CMGC kinase group.

CEP350 MPP3 SRPK1 SRPK2 CPSF4

7.09e-0469536523602568
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

SRPK2 IFT122 PPARA ZNF107 MORN1 MINK1 KLHL26

7.28e-04148936728611215
Pubmed

Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.

PDS5A SRPK1 MYOF MINK1

7.52e-0439936437536630
Pubmed

The cell proliferation antigen Ki-67 organises heterochromatin.

SRPK1 SRPK2 ACTR5 CNOT7

8.32e-0441036426949251
InteractionLCE3D interactions

VWC2L SRPK1 SRPK2 EFEMP2

7.62e-0673354int:LCE3D
InteractionSNRPGP15 interactions

SRPK1 SRPK2 M6PR

2.09e-0531353int:SNRPGP15
InteractionC16orf78 interactions

SRPK1 SRPK2

2.92e-055352int:C16orf78
InteractionCSAG1 interactions

SRPK1 SRPK2

2.92e-055352int:CSAG1
InteractionOCEL1 interactions

SRPK1 SRPK2

2.92e-055352int:OCEL1
InteractionDYRK1A interactions

LRP4 SRPK1 SRPK2 EFEMP2 PPM1G CNOT7 OSBPL1A

3.84e-05552357int:DYRK1A
InteractionYPEL2 interactions

SRPK1 SRPK2

6.12e-057352int:YPEL2
InteractionNOP2 interactions

SRPK1 SRPK2 EZH2 ZNF107 ZNF92 MINK1

7.29e-05416356int:NOP2
InteractionKCNN2 interactions

SRPK1 SRPK2

8.15e-058352int:KCNN2
InteractionCBX6 interactions

CEP350 SRPK2 ZNF214 ZNF107 ZNF92

1.21e-04283355int:CBX6
InteractionMAGEB1 interactions

SRPK1 SRPK2

1.31e-0410352int:MAGEB1
InteractionTRIM28 interactions

PDS5A ZNF208 ZNF90 EZH2 ZNF107 ZNF607 ZNF92 PARP2 PPM1G DPH6

1.43e-0414743510int:TRIM28
InteractionANKRD36B interactions

LRP4 ZNF107 ZNF92

1.53e-0460353int:ANKRD36B
InteractionADPRH interactions

SRPK1 SRPK2

1.60e-0411352int:ADPRH
InteractionSBK1 interactions

SRPK2 PPM1G

1.60e-0411352int:SBK1
InteractionDAW1 interactions

SRPK1 SRPK2

1.60e-0411352int:DAW1
Cytoband19p12

ZNF208 ZNF90

2.29e-039036219p12
CytobandEnsembl 112 genes in cytogenetic band chr19p12

ZNF208 ZNF90

4.16e-03122362chr19p12
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZNF208 ZNF214 ZNF90 ZNF107 ZNF607 ZNF92

5.56e-0471827628
CoexpressionGSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN

ZNF208 PPARA M6PR EFEMP2 DPH6

5.96e-06190365M5361
ToppCellLPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type

MPP3 MYOF SVEP1 EFEMP2

1.88e-051973640a6550dce156fc81f15b1e7830d331ca50d87d06
ToppCell10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

LRP4 BMP1 ZNF214 EFEMP2

1.88e-051973642ca5ebb708935a90b12b8e98a22ae2d664ed002e
ToppCellIIF-Lymphocyte-T_NK-dnT|IIF / Disease, Lineage and Cell Type

IFT122 SVEP1 PPM1G

2.21e-04146363d0f361662db5f7be26104346e8431f7e30c5ce3a
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ZNF208 ZNF214 IFT122

2.79e-04158363d72d6527dc50207ddbada262460d3c4bac249a19
ToppCellLPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

VWC2L MORN1 M6PR

2.89e-041603635d8d97c3da5837ba5fe743d2f8438f5cb7cea64b
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYOF IFT122 ITGA9

3.28e-04167363f01b96173deda0239fa482989873cf308e49d48c
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYOF IFT122 ITGA9

3.28e-041673635fc85a05124cd2324e1b8ff940193880f83cd8af
ToppCellCOVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters

MYOF ZNF90 KLHL26

3.39e-041693636abfdc8b437f19c03b408bedc245059d28c6ba6a
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

VWC2L PPARA SVEP1

3.51e-04171363a5634b76476b8b2488a706bbab5141f7bd94631f
ToppCellCOVID-19_Mild-PLT_2|COVID-19_Mild / Disease Group and Platelet Clusters

MYOF ZNF90 KLHL26

3.63e-04173363d11705e56b6b21eec963ea224717f27680c781ed
ToppCell(0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|(0)_Normal/No_Treatment / Stress and Cell class

LRP4 BMP1 EFEMP2

3.63e-04173363c2a0f674681836b5a868c13f67caa7d555ef6519
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PLA2R1 ITGA9 SVEP1

3.76e-04175363795a6564d5a75ffd35d39f5274b9e8d28708bbc8
ToppCellLPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MPP3 ITGA9 SVEP1

3.88e-04177363b7fee75de7e96924af488a5baa2334711889ae7c
ToppCellmetastatic_Brain-Fibroblasts-Undetermined|metastatic_Brain / Location, Cell class and cell subclass

ZNF208 PLA2R1 EFEMP2

3.88e-0417736354f39be5d90363cfd44dea1a96ae06d3143aa795
ToppCell10x3'2.3-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

LRP4 BMP1 EFEMP2

4.15e-0418136347dce04db3392333eb2f7b9b24c32e6740d2d02f
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MPP3 MYOF ITGA9

4.15e-04181363b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

LRP4 BMP1 EFEMP2

4.15e-0418136319103221c3a5a16b16378348004b2c50caee4f01
ToppCellP28-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

LRP4 PLA2R1 SVEP1

4.35e-04184363924400f47e6b2cdf7b0d538df75857935cf0209b
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MPP3 BMP1 ITGA9

4.35e-04184363ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCellfacs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRP4 BMP1 SVEP1

4.42e-04185363eaa54b76743628c89b4310be57b87fa92b75fd37
ToppCellfacs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRP4 BMP1 SVEP1

4.42e-04185363f7f4c921d248c637351e2e882589b99ba7f04b66
ToppCell(1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|World / Stress and Cell class

LRP4 BMP1 EFEMP2

4.42e-04185363b8cd94cf18308b514fc61557550225794ffd2860
ToppCellfacs-Thymus-Epithelium-24m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRP4 BMP1 SVEP1

4.42e-04185363ff38a15af3dec36d9993f06623591872b5d1da9a
ToppCell10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

MPP3 LRP4 BMP1

4.42e-041853630094f9baddb20214d2a2c166f1637d1a9cf1169a
ToppCell343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells)

ITGA9 EFEMP2 OSBPL1A

4.49e-0418636359db239f1864a5d4f1570c93219dbd7ac5b6db35
ToppCell343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells)

ITGA9 EFEMP2 OSBPL1A

4.49e-041863631bac7825c2fe3e6cdff65026b09b9ccaa40fa27f
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MPP3 MYOF ITGA9

4.49e-041863634e94158db52df41d71e67b02b9895a358eebee0f
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MPP3 BMP1 ITGA9

4.49e-04186363e83718fabb057100835d3357df407f283d23fe16
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MPP3 MYOF ITGA9

4.49e-041863633aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCellE18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass

LRP4 SVEP1 EFEMP2

4.70e-041893630c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCellfacs-Lung-EPCAM-24m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRP4 PLA2R1 SVEP1

4.78e-0419036300fd993675faf53adf985b9316a18c8a33242029
ToppCell10x5'v1-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

PLA2R1 SVEP1 EFEMP2

4.78e-0419036381f8f2cddf4c51b879f315260cd1fca80355a371
ToppCell10x5'v1-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

PLA2R1 SVEP1 EFEMP2

4.78e-04190363877b544decf302e0d41be23dffa1861f79c70914
ToppCell10x5'v1-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

PLA2R1 SVEP1 EFEMP2

4.78e-0419036320106e5213f6a7560554b8b4f84b23c5554ba975
ToppCellfacs-Lung-EPCAM-24m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRP4 PLA2R1 SVEP1

4.78e-041903638cda09d761c6b504a744959d587c183f94f1beeb
ToppCellPND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass

BMP1 ITGA9 EFEMP2

4.85e-041913639bbafdf316c1fa3a9f1ee30d41dd7158b5c97279
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CEP350 PDS5A PPARA

4.85e-0419136360c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCellfacs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LRP4 PLA2R1 SVEP1

4.85e-041913635c4e4e9de14edfae072a2a2882220a31bebf51b2
ToppCelldroplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LRP4 PLA2R1 SVEP1

4.85e-0419136336467322096bc766cd777dae3bfb4e65511e492c
ToppCellControl-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LRP4 ITGA9 SVEP1

4.85e-0419136314057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCelldroplet-Lung-21m-Mesenchymal-fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LRP4 PLA2R1 SVEP1

4.85e-041913638a73d2df079566fca4cbb5cdb85721c2e87134c8
ToppCell(1)_Osterolineage_cells-(10)_OLC-1|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis

LRP4 BMP1 EFEMP2

4.85e-0419136378ad7c555409ce1391bce406bc0f3ef575329ece
ToppCelldroplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LRP4 PLA2R1 SVEP1

4.85e-0419136394795daf05061baa3b72a1b01c9e940af86de044
ToppCellfacs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LRP4 PLA2R1 SVEP1

4.85e-04191363b5210de890d338602857b5907135705a507bc2b0
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CEP350 PDS5A PPARA

4.85e-0419136309db184cb90fe282a14474d7217068c58092c6f8
ToppCelldroplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LRP4 PLA2R1 SVEP1

4.85e-04191363c715bbdbbf1482aad45a50a16d5232fd35a9a0bb
ToppCellfacs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LRP4 PLA2R1 SVEP1

4.85e-0419136380484d39f34703a33b9bac09826b7a526e883cab
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CEP350 PDS5A PPARA

4.85e-04191363973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCelldroplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LRP4 PLA2R1 SVEP1

4.85e-04191363243d83cbfcc4996ad087ec6386e559e0b8662004
ToppCelldroplet-Lung-21m-Mesenchymal|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LRP4 PLA2R1 SVEP1

4.85e-0419136310a9db1caa0fdb51ace8537f42b2c66f7c97e0f5
ToppCellfacs-Trachea-nan-18m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP1 SVEP1 EFEMP2

4.85e-04191363783e8c436de90623bb1bc4117270d60c8c8a9461
ToppCellfacs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LRP4 PLA2R1 SVEP1

4.85e-04191363d4f535b06ad483448ab692e9900c872c78cbed60
ToppCellLPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYOF SVEP1 EFEMP2

4.92e-04192363162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCellfacs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

BMP1 SVEP1 EFEMP2

4.92e-041923637a2e79490e4f7058bb76b46c45b5df9f729e3146
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYOF SVEP1 EFEMP2

4.92e-04192363ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell(0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class

LRP4 BMP1 EFEMP2

4.92e-041923637a2ad0bdae647b88e799e62767605f2f3c5a426f
ToppCellfacs-Trachea-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

BMP1 SVEP1 EFEMP2

4.92e-04192363e8af6ad1ae99cae13a82d0d8d7f38af9b777f0ba
ToppCelldroplet-Limb_Muscle-nan-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP1 SVEP1 EFEMP2

4.92e-041923632d9e2262f1342fe17735f21f733c029d1275e955
ToppCellfacs-Trachea-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

BMP1 SVEP1 EFEMP2

4.92e-04192363fc940f91ff8e051631dbf25e6e8d73cf8337eccb
ToppCellMesenchymal_cells-Ng2+_MSCs|World / Lineage and Cell class

LRP4 BMP1 EFEMP2

4.92e-041923630703b8ec6960ff975ee5a2737054db67cab016b5
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP1 SVEP1 EFEMP2

4.92e-04192363beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCelldroplet-Limb_Muscle-nan-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP1 SVEP1 EFEMP2

5.00e-0419336349600db68ed65cafc67bd45a285b364e4f5f88af
ToppCellfacs-Trachea-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

BMP1 SVEP1 EFEMP2

5.00e-0419336325248b8e65d558b1a96a87c93e3e5b4c0ba168fe
ToppCellfacs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

BMP1 SVEP1 EFEMP2

5.00e-04193363f1f1097204e07a7bed416425b8256942038a734f
ToppCelldroplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP1 SVEP1 EFEMP2

5.00e-0419336345b5cab4dfeb0ed3b13631db5963740a792b810f
ToppCellfacs-BAT-Fat-3m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP1 SVEP1 EFEMP2

5.08e-0419436376b8512fd92014b3ecc42b0a20d6d1df074cba2c
ToppCellfacs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP1 SVEP1 EFEMP2

5.08e-04194363bbc625b4cc53bb7d6254fde287258e51f9171572
ToppCellLPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYOF SVEP1 EFEMP2

5.08e-041943636e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCellfacs-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP1 SVEP1 EFEMP2

5.08e-04194363fcd5e9238d299c41f0bf9693b56cd8c900d2112b
ToppCellfacs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP1 SVEP1 EFEMP2

5.08e-041943636afc21c5fec30ab8e373e3e46ab7866204c805b6
ToppCellfacs-BAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP1 SVEP1 EFEMP2

5.08e-04194363da45811ba07d746e7cba7ed78882b5d98ac7397d
ToppCellmoderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CEP350 IFT122 EZH2

5.08e-04194363dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCellfacs-BAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP1 SVEP1 EFEMP2

5.08e-04194363ef0fa9daecd3bf43c6cf56345928cacdbee19779
ToppCellfacs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP1 SVEP1 EFEMP2

5.15e-0419536369a29d03e664b72f32d41876510c62345c3aed31
ToppCell3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYOF ITGA9 EFEMP2

5.15e-04195363bd7526dd80a60ff7bc866e4f5a0e8acdbc10d191
ToppCellfacs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP1 SVEP1 EFEMP2

5.15e-041953631cffae2b08dbfa1c633ce24023e89b66d28b5431
ToppCellfacs-Trachea-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

BMP1 SVEP1 EFEMP2

5.15e-041953630d1876f6fdc1eafeb60d6fd7da5bce737d2b4a5a
ToppCellfacs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMP1 SVEP1 EFEMP2

5.15e-041953639cef6f18664518060af7c192310dddce6d70345a
ToppCell15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class

BMP1 SVEP1 EFEMP2

5.23e-041963637e178c76285e61c721c38d7a995ebf89dc428f9f
ToppCell15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class

BMP1 SVEP1 EFEMP2

5.23e-0419636354aefcebf13704f51de84379e2e22ec0734b9461
ToppCell10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

LRP4 SVEP1 EFEMP2

5.23e-0419636357df2a57b35be9851ac0b1e5731baa53052511f0
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

MPP3 MYOF ITGA9

5.31e-04197363b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

BMP1 SVEP1 EFEMP2

5.31e-041973632744cc94883c5d0424677cf5093bbab622933e9b
ToppCellMild|World / Condition, Lineage, Cell class and cell subclass

CEP350 ZNF107 MINK1

5.31e-04197363476b0d0389f9fcd4614f6bb1f494281f467f6730
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

MYOF SVEP1 EFEMP2

5.39e-041983630a4b19c3d5e65ecd24fc2ce80ac5276c813282c7
ToppCell10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

LRP4 SVEP1 EFEMP2

5.39e-04198363bc9c9f2c87282b5ef8514773e065d2a6b5dde338
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type

LRP4 BMP1 SVEP1

5.39e-041983630c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

MYOF SVEP1 EFEMP2

5.46e-04199363ba586690f88fd051f449753bfe7603a2cb431782
ToppCell10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

BMP1 SVEP1 EFEMP2

5.46e-04199363d65ee89d5c7e8ed693d58e6a6de09565840e11c5
ToppCellBAL-Control-Myeloid-TRAM-TRAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MYOF M6PR MINK1

5.46e-04199363b8dc5dc9fe3f52be11940d45959134b2a7575a8b
ToppCellBAL-Control-Myeloid-TRAM-TRAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MYOF M6PR MINK1

5.46e-04199363bbf81fb20da8a28aac024207696c6ea00473a0df
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

MYOF SVEP1 EFEMP2

5.46e-0419936330d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

MYOF SVEP1 EFEMP2

5.46e-04199363e1849505b92820a219c5a2c35492bdd55579fb48
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

MYOF SVEP1 EFEMP2

5.46e-0419936338ed3bc7daa993d9edcf3e7834597ebb06dd24f8
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

MYOF SVEP1 EFEMP2

5.46e-0419936306a7d874ff7c4616577f6e59d3118717a8c47c00
ToppCellLPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

LRP4 MYOF ITGA9

5.46e-041993636b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCellBAL-Control-Myeloid-TRAM-TRAM2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

MYOF M6PR MINK1

5.46e-0419936390b20fce27739f28609d664475a197eea586e030
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type

MYOF SVEP1 EFEMP2

5.46e-04199363fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

MYOF SVEP1 EFEMP2

5.46e-04199363a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell(09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition

CEP350 SRPK2 OSBPL1A

5.46e-04199363fc680f85ebd3bab4c72876a19a461b0afb5f51ce
DrugScopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; PC3; HT_HG-U133A

CEP350 BMP1 IFT122 PPARA SVEP1 MINK1

5.12e-071973566335_UP
DrugMonobenzone [103-16-2]; Up 200; 20uM; MCF7; HT_HG-U133A

LRP4 BMP1 MYOF MORN1 EFEMP2

1.07e-051923553391_UP
DrugNadolol [42200-33-9]; Up 200; 13uM; PC3; HT_HG-U133A

LRP4 PPARA SVEP1 EFEMP2 MINK1

1.13e-051943554021_UP
DrugCondelphine [7633-69-4]; Up 200; 8.8uM; PC3; HT_HG-U133A

PDS5A PPARA MORN1 SVEP1 MINK1

1.27e-051993556357_UP
Diseaseschizophrenia (implicated_via_orthology)

TAAR1 PPARA PPM1G

7.91e-0568363DOID:5419 (implicated_via_orthology)
Diseaseosteosarcoma (is_implicated_in)

EZH2 EFEMP2

1.72e-0416362DOID:3347 (is_implicated_in)
DiseaseSynostotic Posterior Plagiocephaly

IFT122 EZH2

1.72e-0416362C1833340
DiseaseSynostotic Anterior Plagiocephaly

IFT122 EZH2

1.72e-0416362C2931150
DiseaseMetopic synostosis

IFT122 EZH2

1.72e-0416362C1860819
DiseaseCraniosynostosis, Type 1

IFT122 EZH2

1.72e-0416362C4551902
DiseaseAcrocephaly

IFT122 EZH2

1.72e-0416362C0030044
DiseaseTrigonocephaly

IFT122 EZH2

1.72e-0416362C0265535
DiseaseScaphycephaly

IFT122 EZH2

1.72e-0416362C0265534
DiseaseBrachycephaly

IFT122 EZH2

1.95e-0417362C0221356
DiseaseCraniosynostosis

IFT122 EZH2

2.71e-0420362C0010278
DiseaseProstatic Neoplasms

PDS5A PPARA EZH2 M6PR EFEMP2

8.61e-04616365C0033578
DiseaseMalignant neoplasm of prostate

PDS5A PPARA EZH2 M6PR EFEMP2

8.61e-04616365C0376358
Diseaseschizophrenia, anorexia nervosa

SRPK2 ACTR5

1.58e-0348362MONDO_0005090, MONDO_0005351
Diseasefeeling "fed-up" measurement

VWC2L LRP4

3.90e-0376362EFO_0009588
DiseaseKidney Diseases

IFT122 PPARA

5.19e-0388362C0022658
DiseaseS-warfarin measurement

PDS5A PPARA

6.27e-0397362EFO_0803323

Protein segments in the cluster

PeptideGeneStartEntry
SKKYGVHVCGEGGEY

DPH6

191

Q7L8W6
EYEEKGGEYLKEHCA

ACTR5

556

Q9H9F9
YEAICGGDVKKDYGH

BMP1

431

P13497
YKKYCLHGEAGKEAA

PDS5A

426

Q29RF7
KVGKAHVYCEGNDVY

PARP2

101

Q9UGN5
MEYKAGGCYEGEVSH

MORN1

101

Q5T089
GHKDTVYCVAYAKDG

IFT122

51

Q9HBG6
KNYDGKVHGDRECGF

EZH2

151

Q15910
CGLFGKELHKVEGYI

OSBPL1A

746

Q9BXW6
EEYKKKYGEEHGSCQ

ITGA9

181

Q13797
DDAKYCGHLYGLGSG

CNOT7

251

Q9UIV1
GGYGISVEDKKALHC

KLHL26

466

Q53HC5
TYDGIAYFECKEKHG

CEP350

2541

Q5VT06
GYSVKCEYSAHKEGV

C20orf27

101

Q9GZN8
EQVTCYKCGEKGHYA

CPSF4

241

O95639
KGEMKCINHYGGYLC

EFEMP2

66

O95967
DYAQGAYGVKKDHCL

CPHXL

281

A0A1W2PPM1
GDKASGYHYGVHACE

PPARA

106

Q07869
DKETCDCEGYLKGHY

MPP3

321

Q13368
GDMEGCGHYRVVKYE

MINK1

1111

Q8N4C8
GHGGEEVALYCAKYL

PPM1G

61

O15355
DYCKGGYHLVKIGDL

SRPK1

61

Q96SB4
GHFECICEKGYYGKG

SVEP1

301

Q4LDE5
YGSGGGDICEYLHKD

PLA2R1

151

Q13018
IHTGEKPYKCGDYGR

ZNF107

741

Q9UII5
DHKSVDACKVYKGGY

ZNF92

116

Q03936
IYKGGDEYDNHCGKE

M6PR

121

P20645
ADYCKGGYHPVKIGD

SRPK2

61

P78362
YSGEKHYECKENGEA

ZNF607

331

Q96SK3
KGAEEIYYKHVHCRG

TAAR1

166

Q96RJ0
GASYEKIKEVIGHGC

TTLL2

306

Q9BWV7
GCESVDEGKVHKRGY

ZNF90

116

Q03938
GYTNVDECKVHKEGY

ZNF208

116

O43345
KGCVDDSGFVYKLGE

VWC2L

51

B2RUY7
GKKLYGCDEVDGNFH

ZNF214

271

Q9UL59
CYKKEGGPDHNYTKE

LRP4

1791

O75096
SGEHEKCGQYIQKGY

MYOF

1461

Q9NZM1